BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 16728286)

  • 21. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lack of correlation between an assay used to determine early marrow allograft rejection and long-term chimerism after murine allogeneic bone marrow transplantation: effects of marrow dose.
    Koh CY; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2005 Apr; 11(4):252-9. PubMed ID: 15812390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
    Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
    Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-CD25 mAb, anti-IL2 mAb, and IL2 block tolerance induction through anti-CD154 mAb and rapamycin in xenogeneic islet transplantation.
    Pan H; Lu HM; Hu WM; Tian BL; Liu XB; Zhang ZD; Mai G
    Transplant Proc; 2007 Dec; 39(10):3452-4. PubMed ID: 18089405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.
    Wang X; Wang W; Xu J; Le Q
    Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclosporine A and peripheral tolerance. Inhibition of veto cell-mediated clonal deletion of postthymic precursor cytotoxic T lymphocytes.
    Hiruma K; Gress RE
    J Immunol; 1992 Sep; 149(5):1539-47. PubMed ID: 1387142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressor T cells in allogeneic bone marrow chimeras.
    Leshem B; Lebendiker Z; Weiss L; Slavin S; Kedar E
    Bone Marrow Transplant; 1987 Aug; 2(2):123-32. PubMed ID: 2901877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys.
    Ma A; Qi S; Song L; Hu Y; Dun H; Massicotte E; Dupuis M; Daloze P; Chen H
    Int Immunopharmacol; 2011 May; 11(5):618-29. PubMed ID: 21094689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow cells from allogeneic bone marrow chimeras inhibit the generation of cytotoxic lymphocyte responses against both donor and recipient cells.
    Ogasawara M; Iwabuchi K; Good RA; Onoe K
    J Immunol; 1988 Nov; 141(10):3306-12. PubMed ID: 2972771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice.
    Yoshida A; Narumi S; Hashimoto N; Itabashi Y; Hakamada K; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2418-22. PubMed ID: 15561266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4+CD25+ cells in the recipient.
    Zheng SG; Meng L; Wang JH; Watanabe M; Barr ML; Cramer DV; Gray JD; Horwitz DA
    Int Immunol; 2006 Feb; 18(2):279-89. PubMed ID: 16415106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Keratinocyte growth factor improves allogeneic bone marrow engraftment through a CD4+Foxp3+ regulatory T cell-dependent mechanism.
    Bruinsma M; van Soest PL; Leenen PJ; Löwenberg B; Cornelissen JJ; Braakman E
    J Immunol; 2009 Jun; 182(12):7364-9. PubMed ID: 19494258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection.
    Nishida T; Hosaka N; Takaki T; Miyake T; Cui W; Inaba M; Kinoshita H; Matsuda T; Ikehara S
    Bone Marrow Transplant; 2009 Jun; 43(11):829-37. PubMed ID: 19079314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
    Wang J; Zhang L; Tang J; Jiang S; Wang X
    Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study on the veto cells from H-2 recombinant mice and allogeneic bone marrow chimeric mice].
    Ogasawara M
    Hokkaido Igaku Zasshi; 1986 Nov; 61(6):883-91. PubMed ID: 2951312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapamycin promotes emergence of IL-10-secreting donor lymphocyte infusion-derived T cells without compromising their graft-versus-leukemia reactivity.
    Durakovic N; Radojcic V; Powell J; Luznik L
    Transplantation; 2007 Mar; 83(5):631-40. PubMed ID: 17353785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.